Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705913 · ClinicalTrials.gov registry record · NA
Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna
A NA study, sponsored by Sorin Group USA.
- Terminated
- Registry status
- NA
- Development phase
- 368
- Enrollment target
NCT00705913: Clinical Trial NA study, sponsored by Sorin Group USA.
NCT00705913 is a NA study that was terminated before completion, run by Sorin Group USA. The registered enrollment target is 368 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00705913, a NA study, was terminated before completion, sponsored by Sorin Group USA.
- TERMINATED
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
Study Summary
The purpose of this study is to compare sizing,implant techniques, and hemodynamics between the Mitroflow Pericardial Aortic Valve and the Edwards Magna Heart Valve.
Interventions
- DEVICE Mitroflow Aortic Pericardial Heart Valve (CarboMedics)
- DEVICE Carpentier-Edwards Magna Tissue Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-09 |
| Phase | NA |
Why NCT00705913 stopped before completion
NCT00705913 is an interventional study that assigns participants to a tested intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which Mitroflow Aortic Pericardial Heart Valve (CarboMedics) is the first listed.
NCT00705913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00705913 about?
NCT00705913 is a clinical study titled "Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna". The purpose of this study is to compare sizing,implant techniques, and hemodynamics between the Mitroflow Pericardial Aortic Valve and the Edwards Magna Heart Valve.
What is the current status of trial NCT00705913?
This trial is currently terminated. It is a NA study. The enrollment target is 368 participants. The study started on 2008-06. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00705913?
The interventions under investigation include: Mitroflow Aortic Pericardial Heart Valve (CarboMedics) (DEVICE), Carpentier-Edwards Magna Tissue Valve (DEVICE).
Who is sponsoring clinical trial NCT00705913?
This trial is sponsored by Sorin Group USA, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00705913's enrollment target sits among peer trials
368 283rd of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia